Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer|February 25, 2022
De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohortYu-Wen Cai, Zhi-Ming Shao, Ke-Da YuFrontiers in Immunology|July 18, 2022
Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome: A Network Meta-AnalysisYu-Wen Cai, Zhi-Ming Shao, Ke-Da YuCancer Communications (London, England)|July 12, 2021
Estrogen receptor-low breast cancer: Biology chaos and treatment paradoxKe-Da Yu, Yu-Wen Cai, Song-Yang Wu, et al.The Journal of Clinical Investigation|November 12, 2024
MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor-positive HER2-negative breast cancerYu-Wen Cai, Cui-Cui Liu, Yan-Wu Zhang, et al.Cell Reports. Medicine|January 30, 2024
Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancerCui-Cui Liu, Lie Chen, Yu-Wen Cai, et al.Signal Transduction and Targeted Therapy|February 18, 2025
Breast cancer: pathogenesis and treatmentsXin Xiong, Le-Wei Zheng, Yu Ding, et al.World Journal of Clinical Cases|December 8, 2021
Deep learning driven colorectal lesion detection in gastrointestinal endoscopic and pathological imagingYu-Wen Cai, Fang-Fen Dong, Yu-Heng Shi, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 3, 2023
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early DisseminationYi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, et al.Protein & Cell|January 13, 2026
Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph NodesLinhui Zhai, Cui-Cui Liu, Lei Zhao, et al.Pageof 1